Obtained results demonstrate that TMEM244 mRNA is necessary for cellular growth of CTCL cells; therefore, it might be considered a new therapeutic target for the treatment of CTCL. The gene discussed is TMEM244; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.